Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × Rivaroxaban × Clear all

NCT03139487 2020-01-06

PRIORITY

Biliary Tract Neoplasms, Duodenal Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Stomach Neoplasms, Cholangiocarcinoma, Gastrointestinal Stromal Tumors